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INTRODUCTION
The incidence of stroke is generally higher in men than in
women, but this difference decreases above age 65 (1). Pre-
menopausal women seem to be protected against cardiovas-
cular morbidity and mortality as compared with postmeno-
pausal women of a similar age (2, 3). The loss of ovarian func-
tion and the subsequent endogenous estrogen deficiency have
been suggested to increase the risk of cardiovascular disease
and death after menopause (4, 5). Moreover, if endogenous
estrogen protects against stroke, an early menopause might
incur a higher risk, because of a lower exposure to estrogen.
However, evidence supporting this hypothesis is inconclusive
(6-10), and most studies have limitations.
An 18-yr study of 35,616 naturally postmenopausal women,
age at natural menopause was not found to be significantly
associated with ischemic or hemorrhagic stroke (6). Other
studies that reported an insignificant association between
age at menopause and severe stroke leading to death investi-
gated mortality risk due to stroke, and not the total risk of
incidental stroke (7, 8). These studies also investigated the
mortality risk of stroke by combining ischemic and hemor-
rhagic stroke, and did not investigate them separately (7, 8).
However, in a 20-yr study of 12,115 women, an early meno-
pause was found to be significantly associated with a higher
risk of cardiovascular death (9), but the study was designed
to investigate the association between age at menopause and
total cardiovascular mortality, which included stroke and coro-
nary heart disease as a single entity. The study found that wo-
men with a late menopause had significantly less atheroscle-
rosis of the carotid artery than women with an early meno-
pause, but was limited, because women with a natural meno-
pause and women with an artificial menopause due to surgery
were not segregated (10). Moreover, sex hormone concentra-
tions in postmenopausal women seem to decrease with time
since menopause (11). However, no study has been conducted
on the association between time since menopause and stroke.
Stroke occurs more frequently among Asians and Blacks
than among Caucasians (1, 12, 13). However, to the best of
our knowledge, the association between age at menopause
and stroke has not yet been studied in Asian countries. Thus,
the aim of this study was to examine the association between
age at menopause or time since menopause and the risk of
stroke in Korean elderly women that had experienced a nat-
ural menopause.
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Natural Menopause and Risk of Stroke in Elderly Women
Although early natural menopause has been postulated to increase stroke risk, stud-
ies have not produced convincing results. We examined the associations between
stroke risks and age at natural menopause or time since natural menopause. 5,731
naturally postmenopausal women more than 65 yr of age were followed from 1993
to 1998. Information on age at menopause and risk factors were obtained using
mailed questionnaires. 186 cases of stroke occurred over a total 27,936 person-
years. After adjusting for age, hypertension, and physical activity, age at menopause
was not found to be significantly associated with stroke or cerebral infarction. How-
ever, adjusted relative risks (aRRs) showed a significant increasing tendency of
hemorrhagic stroke versus age at menopause (aRRs, 0.66, 0.48, 1.00 and 2.33
for the following age groups at menopause; 40-44, 45-49, 50-54 [reference group],
and ≥55 yr). Time since menopause (11-20, 21-30, and ≥31 yr) was not found
to be significantly associated with cerebral infarction, or hemorrhagic stroke. Late
menopause (menopause age ≥55 yr) showed a tendency of a lower risk of cere-
bral infarction (aRR, 0.79) and a higher risk of hemorrhagic stroke (aRR, 2.33). Fur-
ther study is warranted to determine stroke risk in women during the decade follow-
ing menopause.
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MATERIALS AND METHODS
Subjects and assessment of risk factors
The Korean Elderly Pharmacoepidemiologic Cohort
(KEPEC) was a dynamic cohort that consisted of 46,113 ben-
eficiaries of the Korean Medical Insurance Corporation (KMIC)
between 1993 and 1998. The subjects were the parents of
school teachers or government employees in Busan, Korea,
and were aged 65 yr or more (14). The total number of wo-
men registered by the KEPEC was 28,883, and 9,573 of these
responded to a baseline survey instigated via a mailed ques-
tionnaire, and provided written consent. In addition, 6,468
women reported age at menopause on the questionnaire survey.
The baseline survey self-administered questionnaire had
been previously evaluated and found to have good validity
medical history, smoking (never, ex-smoker, current-smoker),
alcohol consumption (never, ex-drinker, current-drinker),
weight, height, salt diet (low, medium, high), physical activ-
ity (frequency of climbing stairs above ten; rare, sometimes,
often), parity, age at first birth, age at last birth, breast feed-
ing, history of hysterectomy or ovariectomy, and use of post-
menopausal hormones. In a validation study using a subsam-
ple of the KEPEC, the reliability coefficients of age at meno-
pause were 0.99 for self-self response and 0.60-0.80 for self-
proxy response (15). 
Data on 93 women with stroke at baseline, on 24 women
not regarded as reliable with respect to reported age at meno-
pause, and on 95 women who used postmenopausal hormones
were excluded (no case of stroke occurred in this latter group
during the follow-up period). Finally, the data of 525 women
who had undergone hysterectomy or ovariectomy were also
excluded, because we could not confirm whether these were
the causes of menopause. The remaining 5,731 naturally post-
menopausal women of more than 65 yr of age were composed
our study subjects. All of the study subjects had experience
of breast-feeding. We should add that the proportion of wo-
men with a biological age of ≥80 was larger in the 23,152
women not included in the present analysis than in the 5,731
women included (10.9% vs. 6.6%).
Ascertainment of stroke 
Potential incident cases of stroke that occurred between 1
January 1993 and 31 December 1998 were identified from;
claim data at medical care institutions in Busan, mortality
data from the Korean National Statistical Office (KNSO), and
from women who reported having experienced a stroke dur-
ing this follow-up period on the questionnaire.
Subjects admitted at hospitals with a diagnosis of Interna-
tional Classification of Diseases, Ninth Revision, Clinical Mo-
dification (ICD-9-CM) 430-434, 436-438 between 1993 and
the first half of 1995, or ICD-10/I60-I69 between the latter
half of 1995 and 1998, were screened from the claims data.
Trained medical students visited the hospitals at which poten-
tial cases were admitted to review and abstract medical records
using a standard abstracting form. Two neurologists reviewed
the abstract forms blindly. Ninety-two cases were designat-
ed as confirmed cases based on their fulfilling at least one of
the symptoms detailed by the World Health Organization
(WHO), i.e., as rapidly developing signs of focal (or global)
disturbance of cerebral function (lasting longer than 24 hr
or leading to death) without apparent cause other than a vas-
cular origin (16), ICD-9-CM 430-434, 436-438 or ICD-10/
I60-I69 on discharge summary, or a brain CT or MRI find-
ing of acute stroke. We included spontaneous subarachnoid
hemorrhage, but excluded subdural and extradural hematomas
and transient ischemic attacks. 
During the period 1993 to 1998, six deaths due to a diag-
nosis of ICD-9-CM 430-434, 436-438 or ICD-10/I60-I69
were found among mortality data from KNSO. Seventy-three
women reported having experienced a stroke during the fol-
low-up period on the questionnaire. In addition to these, 15
cases, for which no medical records were available, but who
were admitted with a diagnosis of stroke on claims data, were
designated as probable cases.
All cases confirmed by reviewing medical records and prob-
able cases were included in the data analysis, because when
we excluded probable cases we obtained near identical results
(data not shown). All cases were classified as cerebral infarc-
tion, hemorrhagic stroke, or stroke of an unclassified type
according to neuroimaging findings, ICD-9-CM or ICD-10.
Statistical analysis
Age at menopause was categorized into 5 groups (i.e., <40,
40-44, 45-49, 50-54 [reference group], ≥55 yr) (6, 7), and
time since menopause was categorized into 3 groups (i.e., 11-
20 [reference group], 21-30, ≥31 yr). Ninety-three women
with a time since menopause of ≤10 yr were excluded from
the analysis. The risk of stroke for those ≤10 yr since meno-
pause could not be assessed, because women who experienced
natural menopause at an average age and stroke before age 65
were excluded from the present study. The starting point of
the follow-up period was the latest date among the date on
which any subject reached 65 yr old, the date of becoming a
beneficiary of the KMIC in Busan, or 1 January 1993. The
end point was the earliest date among the onset date of stroke,
the date of death, or 31 December 1998. 
Differences in the proportions of potential confounders by
age at menopause were assessed using the chi-square test.
Crude relative risk (cRR) of all strokes was computed as the
rate in a specific category divided by that in the reference cat-
egory of each potential confounder. Confounders that were
differently distributed at p<0.1 and had a significantly high
cRR of stroke at p<0.05, were included in the multivariate
analysis using Cox’s proportional hazard model to examine
the association between age at menopause or time since me-Natural Menopause and Stroke 1055
nopause and stroke. We also considered age at menopause as
a continuous variable and estimated the adjusted RRs (aRRs)
of stroke for each 1-yr increase.
Differences in times between menopause and the onset of
any stroke or cerebral infarction for the age at menopause
groups were assessed by ANOVA. Difference in times bet-
ween menopause and the onset of hemorrhagic stroke among
these same groups was assessed using the Kruskal-Wallis test.
RESULTS
The mean age of the 5,731 study subject at the time of en-
rollment was 69.8±5.5 yr, and their mean age at natural me-
nopause was 49.6±4.6 yr. History of diabetes mellitus (DM),
alcohol intake, salt in diet, parity, and age at first birth were
not significantly related to age at menopause. An earlier me-
nopause was associated with a history of hypertension, a lower
body mass index (BMI), a younger age at enrollment and at
last birth, current smoking, and more frequent exercise (p<0.1)
(Table 1). 
During 27,936 person-yr of follow-up, 186 incident cases
of stroke (93 of cerebral infarction, 20 of hemorrhagic stroke,
and 73 of an unclassified type) occurred. The incidence den-
sities of all strokes, cerebral infarction, and hemorrhagic stroke
were 666 (95% confidence interval [CI], 570-762), 333 (95%
CI, 265-401) and 72 (95% CI, 40-103) per 100,000 person-
years, respectively.
Women with histories of hypertension or DM were found
to have an increased risk of stroke, with cRRs of 2.13 (95%
CI, 1.49-3.04) and 1.61 (95% CI, 1.01-2.56), respectively.
Women who climbed more than ten stairs sometimes or often
were at lower risk of stroke (cRR=0.52 and 95% CI, 0.35-
0.78, in the ‘‘sometimes’’ group; cRR=0.43 and 95% CI,
0.30-0.62, in the ‘‘often’’ group). No significant changes in
the cRRs of stroke were found for; age at enrollment, BMI,
smoking status, alcohol intake, salt diet, parity, age at first
birth, or age at last birth. 
After adjusting for age at enrollment, physical activity, and
history of hypertension the aRRs for all strokes were 1.25
(95% CI, 0.39-3.95), 0.68 (95% CI, 0.35-1.31), 0.98 (95%
CI, 0.71-1.36), and 0.91 (95% CI, 0.59-1.41) for natural me-
Characteristics
Age at enrollment (yr) 65-69 3,401 76.2% 61.2% 56.9% 59.6% 61.2% 0.051
70-74 1,233 15.5% 21.0% 22.3% 22.3% 22.1%
75-79 695 4.8% 10.5% 13.3% 13.3% 10.4%
80≤ 402 3.6% 7.2% 7.6% 6.9% 6.3%
Hypertension 685 14.3% 15.0% 10.3% 12.3% 12.8% 0.047
Diabetes mellitus  444 9.5% 7.9% 7.1% 8.1% 7.8% 0.75
Body mass index <18.5 775 11.2% 15.6% 15.5% 14.0% 10.4% 0.003
18.5-24.9 3,680 68.8% 66.6% 67.1% 66.8% 63.4%
25≤ 1,062 20.0% 17.8% 17.4% 19.3% 23.0%
Smoking status  Never 3,813 71.6% 69.1% 68.9% 72.5% 68.2% 0.092
Former 397 2.7% 7.2% 8.3% 7.2% 6.3%
Current 1,138 25.7% 23.8% 22.9% 20.2% 17.9%
Alcohol intake  Never 4,226 81.7% 77.2% 74.5% 75.7% 74.1% 0.21
Former 231 2.4% 3.4% 4.0% 4.7% 3.2%
Current 1,155 15.9% 19.4% 21.5% 19.6% 22.6%
Physical activity Rare 2,342 32.9% 43.2% 42.7% 42.2% 39.5% 0.062
Sometimes 1,266 17.1% 23% 22.9% 21.6% 25.5%
Often 1,985 50.0% 33.7% 34.4% 36.2% 35.0%
Salt diet Low 748 10.8% 12.7% 13.5% 13.0% 13.2% 0.11
Medium 3,565 65.1% 60.1% 61.3% 64.8% 60.1%
High 1,378 24.1% 27.2% 25.2% 22.2% 26.6%
Parity 0-2 464 8.5% 11.4% 7.3% 8.0% 9.1% 0.19
3-5 2,223 41.5% 35.4% 39.2% 39.4% 40.6%
6≤ 2,975 50.0% 53.2% 53.5% 52.6% 50.4%
Age at first birth (yr) ≤19 1,047 30.6% 26.4% 26.2% 26.9% 27.7% 0.36
20-24 2,462 53.1% 66.1% 63.9% 62.7% 60.1%
25≤ 405 16.3% 7.5% 9.9% 10.4% 12.2%
Age at last birth (yr) ≤34 1,272 50.0% 40.2% 31.6% 30.9% 36.5% <0.001
35-38 1,002 43.5% 30.9% 26.0% 25.1% 23.9%
39≤ 1,600 6.5% 28.9% 42.4% 44.0% 39.6%
Table 1. Subject sociodemographic characteristics and their distributions by age at natural menopause
*p-value by 
2-tests.
Age at menopause (yr)
All (number)
n=5,731 <40
n=84
55≤
n=858
50-54
n=2,555
45-49
n=1,806
40-44
n=428
p value*nopause at age <40, 40-44, 45-49, and ≥55 yr, respectively.
Further adjustment by age at last birth, BMI, smoking sta-
tus, and history of DM did not substantially change these esti-
mates (data not shown). The aRR of all strokes was 1.00 (95%
CI, 0.97-1.03) for single-year increase interval of age at me-
nopause. For classifiable cerebral infarction and hemorrhagic
stroke, no significant changes in aRR were observed in the
different age at menopause categories. However, aRRs showed
a significant increasing tendency on increasing age at meno-
pause with respect to hemorrhagic stroke (Table 2).
After adjusting for age, a history of hypertension, and physi-
cal activity, the aRRs of all strokes among those with a time
since menopause of 21-30 or >31 yr were 1.08 (95% CI, 0.69-
1.71) and 1.09 (95% CI, 0.53-2.24), respectively. Also, no
significant changes were observed in aRRs of cerebral infarc-
tion or hemorrhagic stroke among the higher categories of
time since menopause.
For the five age at menopause groups (<40, 40-44, 45-49,
50-54 and ≥55 yr), the time intervals between age at meno-
pause and strokes were 29.7±0.4, 32.2±6.4, 27.6±6.0,
22.9±5.7 and 14.8±4.8 yr, and for cerebral infarction were
30.2, 31.5±4.4, 26.9±4.7, 23.8±5.8 and 14.8±4.8 yr.
Differences between these times were significant for all strokes
(F [4, 181]=29.7, p<0.001) and for cerebral infarction (F [4,
88]=12.9, p<0.001). The mean times between menopause
and the onset of hemorrhagic stroke were 27.3, 30.7±8.5,
21.0±4.3 and 13.6±7.2 yr, for four age at menopause gro-
ups (40-44, 45-49, 50-54 and ±55 yr), respectively, and
these time intervals for the four groups were significantly dif-
ferent (p<0.05).
DISCUSSION
In this prospective cohort study, we found no significant
association between a younger age at menopause and a high-
er risk of stroke or of cerebral infarction among women ≥65
yr old who experienced a natural menopause and had never
used postmenopausal hormone. 
Women who had experienced younger age at menopause
and a stroke before reaching 65 yr old were excluded from
this elderly cohort. This might have resulted in no significant
association between a younger age at menopause and a higher
risk of stroke. However in a 20-yr study of 35,616 women
aged 30 to 50 yr, age at natural menopause was not found to
be significantly associated with stroke (6).
Because the proportion of women with a younger age at
menopause was smaller in our study than in previously report-
ed studies (1.5% vs. 2.4-4.5% and 7.5% vs. 10-11%, for age
at menopause of <40 yr and 40-45 yr, respectively) (7-9), the
association between a younger age at menopause and a high-
er risk of stroke might not have been significant. However,
in studies with a higher proportion of women with a younger
age at menopause, age at natural menopause was found not
to be significantly associated with cardiovascular mortality
(7, 8). 
The risk of cardiovascular mortality due to early menopause
has been reported to decrease with increasing biological age
(7, 9). However, as the mean age of subjects in the present
study was older than those of previous studies (7, 8), this asso-
ciation between an early menopause and stroke risk might not
have been significant.  
The statistical power of the present study was high, 97.7%
(Z , -1.99). In a previous autopsy-based study, degree of athe-
rosclerosis was found to rise steadily with increasing biolog-
ical age (18), however, no association was found between athe-
rosclerosis severity and age at menopause. 
Menopause and early menopause were found to be associ-
ated with the presence of carotid atherosclerosis in two case-
control studies (10, 19). However, in several large-scale pros-
pective studies with a long-term follow-up, age at natural
menopause was not found to be associated with the risk of
stroke (6-8, 20). Recently, the Heart and Estrogen/Progestin
Replacement Study (HERS) found no overall reduction in
the risk of stroke among those administered estrogen plus
progestin in a randomized, blind, placebo-controlled trial
among postmenopausal women with coronary heart disease
(21, 22). Hormone replacement therapy was found to be asso-
1056 S.H. Choi, S.-M. Lee, Y. Kim, et al.
Age at 
meno- Person- Cases cRR aRR
pause years (n) (95% CI) (95% CI)*
(yr)
Table 2. Crude and adjusted relative risks and their 95% confiden-
ce intervals (CI) for stroke by age at natural menopause among
5,731 postmenopausal women
All strokes
�
<40 370 3 1.18 (0.37-3.73) 1.25 (0.39-3.95)
40-44 2,064 10 0.70 (0.36-1.34) 0.68 (0.35-1.31)
45-49 8,914 60 0.96 (0.69-1.34) 0.98 (0.71-1.36)
50-54 12,474 87 1.00 1.00
55≤ 4,114 26 0.90 (0.58-1.41) 0.91 (0.59-1.41)
Cerebral infarction
<40 370 1 0.81 (0.11-5.90) 0.87 (0.12-6.34)
40- 44 2,064 4 0.57 (0.20-1.57) 0.56 (0.20-1.55)
45-49 8,914 34 1.10 (0.70-1.73) 1.12 (0.72-1.76)
50-54 12,474 43 1.00 1.00
55≤ 4,114 11 0.78 (0.40-1.52) 0.79 (0.41-1.53)
Hemorrhagic stroke
<40 0 0
40-44 2,064 1 0.67 (0.09-5.31) 0.66 (0.08-5.17)
45-49 8,914 3 0.47 (0.13-1.72) 0.48 (0.13-1.75)
50-54 12,474 9 1.00 1.00
55≤ 4,114 7 2.35 (0.88-6.31) 2.33 (0.87-6.25)
p value for linear trend
� 0.02
*, Adjusted relative risk by Cox’s proportional hazard model analysis for
age at enrollment, physical activity, and a history of hypertension. 
� , Strokes
of an unclassified type were included in all strokes but were not analyzed
separately. 
� , p value determined using likelihood ratio test for the linear
trend. ciated with an elevated risk of ischemic stroke (23). It was
also reported that long-term hormone therapy increases platelet
activation significantly and that this may contribute to throm-
boembolism development (24). 
We observed that the aRRs of hemorrhagic stroke showed
a significant increasing tendency as age at menopause increas-
ed. A case-control study showed a significant association bet-
ween a younger age at menarche and higher risk of intracere-
bral hemorrhage or subarachnoid hemorrhage (25). And, the
case-controlled study found that the risks of intracerebral he-
morrhage or subarachnoid hemorrhage are significantly high-
er in women with an age at menopause of 47-49 yr than in
women with an age at menopause of ≤46 yr. Moreover, a
longer exposure to estrogen may be associated with a high
risk of hemorrhagic stroke. However, 73 cases of stroke were
unclassified in the present study. Thus the rate of cerebral
infarction or hemorrhagic stroke determined by the present
study might have been lower than the true rate, and the reli-
ability of our results on the associations between cerebral in-
farction or hemorrhagic stroke and age at menopause or time
since menopause might be limited. 
In the present study, increased time since natural meno-
pause was not found to be associated with a higher risk of
stroke. Moreover, natural menopause causes a gradual, rather
than an abrupt, decline in estrogen production (6). And, the
risks of cardiovascular mortality or total mortality, including
stroke, due to early menopause have been reported to show
a decreasing trend vs. biological age (7, 9). Thus an increase
in time since menopause may not be associated with a risk
of stroke. However, in the present study, we were unable to
assess the risk of stroke in those with a time since menopause
of ≤10 yr. Further study is warranted to determine stroke
risk in women during the decade following menopause.
The times between menopause and stroke onset seemed
to increase with decreasing age at menopause. The sums of
mean ages at menopause and the mean times between me-
nopause and stroke onset fell in the range 70 to 74 yr for all
five age at menopause groups (<40, 40-44, 45-49, 50-54,
≥55 yr). This result indicates that age at menopause is not
associated with the risk of stroke. 
The proportion of women with a biological age of ≥80 yr
was larger among non-participants in the present analysis,
probably because women of this age were unable to respond
to the questionnaire due to illiteracy, disease, or indifference.
Moreover, elderly women above 80 yr that had experienced
a stroke might have been unable to complete the question-
naire. Thus the incidence densities of stroke in this study may
have be underestimated. 
The accuracy of the present study in terms of assessing risk
factors may be limited by the use of a questionnaire approach
as compared with direct blood testing or physical examina-
tions. Some women at risk of stroke did not realize that they
had risk factors. The presence of hypercholesterolemia was
not investigated in this study.  
In the present study, we reviewed the medical records of
only those stroke cases treated at conventional hospitals in
Busan, and thus we cannot comment on those treated at hos-
pitals in areas other than Busan or on those that received tradi-
tional (oriental) medical care. Thus, we might have included
false positive cases among stroke events. However, after ex-
cluding probable cases our results were virtually the same as
those obtained when probable cases were included. Our study
also has the limitation that it did not examine the association
between stroke risk and age at natural menopause in women
younger than 65 yr.
In summary, we found no significant association between
the risk of stroke for any cause or the risk of cerebral infarc-
tion and a younger age at menopause or time since meno-
pause, among women over 65 yr of age who had experienced
a natural menopause and had never used hormone therapy.
For hemorrhagic stroke, we observed a significant tendency
for aRRs to increase as age at menopause increased. Further
study of the possible associations between the risk of stroke
and a younger age at menopause, or time since menopause
among women younger than 65 yr, is warranted.
ACKNOWLEDGMENTS
We appreciate the help of the staff at the National Health
Insurance Corporation and of medical students at Seoul Na-
tional University College of Medicine who participated in the
hospital survey.
REFERENCES
1. Dyken ML, Wolf PA, Barnett HJM, Bergan JJ, Hass WK, Kannel
WB, Kuller L, Kurtzke JF, Sundt TM. Risk factors in stroke. A state-
ment for physicians by the Subcommittee on risk factors and stroke of
the Stroke Council. Stroke 1984; 15: 1105-11.
2. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause
and risk of cardiovascular disease. The Framingham study. Ann Intern
Med 1976; 85: 447-52.
3. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause
and coronary heart disease. The Framingham Study. Ann Intern Med
1978; 89: 157-61.
4. Parrish HM, Carr CA, Hall DG, King TM. Time interval from cas-
tration in premenopausal women to development of excessive coro-
nary atherosclerosis. Am J Obstet Gynecol 1967; 99: 155-62.
5. Robinson RW, Higano N, Cohen WD. Increased incidence of coro-
nary heart disease in women castrated prior to the menopause. Arch
Int Med 1959; 104: 908-13.
6. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Man-
son JE, Rosner B, Stampfer MJ. Age at natural menopause and risk
of cardiovascular disease. Arch Intern Med 1999; 159: 1061-6.
7. Snowdon DA, Kane RL, Beeson WL, Burke GL, Sprafka JM, Potter
J, Iso H, Jacobs DR Jr, Phillips RL. Is early natural menopause a
Natural Menopause and Stroke 1057biologic marker of health and aging? Am J Public Health 1989; 79:
709-14.
8. Cooper GS, Sandler DP. Age at natural menopause and mortality.
Ann Epidemiol 1988; 8: 229-35.
9. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans
MJC, Banga JD. Age at menopause as a risk factor for cardiovas-
cular mortality. Lancet 1996; 347: 714-8.
10. Joakimsen O, B naa KH, Stensland-Bugge E, Jacobsen BK. Popu-
lation-based study of age at menopause and ultrasound assessed ca-
rotid atherosclerosis. The Troms study. J Clin Epidemiol 2000; 53:
525-30. 
11. Vermeulen A, Verdonck L. Sex hormone concentrations in post-me-
nopausal women. Relation to obesity, fat mass, age and years post-
menopause. Clin Endocrinol 1978; 9: 59-66.
12. Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence
in Hawaii Japanese men. The Honolulu Heart Study. Stroke 1980;
11: 14-21.
13. Worth RM, Kato H, Rhoads GG, Kagan A, Syme SL. Epidemiologic
studies of coronary heart disease and stroke in Japanese men living
in Japan, Hawaii and California: mortality. Am J Epidemiol 1975;
102: 481-90. 
14. Park BJ, Cho YK, Kim SA. Construction of the Korea Elderly Phar-
macoepidemiologic Cohort: drug utilization review of cephalosporins
in geriatric inpatients. Pharmacoepidemiol Drug Saf 2001; 10: 487-92.
15. Park BJ, Kim DS, Koo HW, Bae JM. Reliability and validity study
of a life style questionnaire for elderly people. Korean J Prev Med
1998; 31: 49-58.
16. The World Health Organization. MONICA Project (monitoring of
trends and determinants in cardiovascular disease): a major interna-
tional collaboration. WHO Monica Project principal investigators.
J Clin Epidemiol 1988; 41: 105-14.
17. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and all-
cause mortality: a 37-year follow-up of 19,731 Norwegian women.
Am J Epidemiol 2003; 157: 923-9.
18. Ackerman RF, Dry TJ, Edwards JE. Relationship of various factors
to the degree of coronary atherosclerosis in women. Circulation 1950;
1: 1345-54.
19. Dobs AS, Nieto FJ, Szklo M, Barnes R, Sharrett AR, Ko WJ. Risk
factors for popliteal and carotid wall thicknesses in the atheroscle-
rosis risk in communities (ARIC) study. Am J Epidemiol 1999; 150:
1055-67.
20. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and stroke
mortality: cohort study with 3561 stroke deaths during 37-year follow-
up. Stroke 2004; 35: 1548-51.
21. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vit-
tinghoff E. Randomized trial of estrogen plus progestin for secondary
prevention of coronary heart disease in postmenopausal women. JAMA
1998; 280: 605-13. 
22. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlat-
ky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vit-
tinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8
years of hormone therapy. Heart and Estrogen/Progestin Replacement
Study follow-up (HERS II). JAMA 2002; 288: 49-57.
23. Bath PM, Gray LJ. Association between hormone replacement ther-
apy and subsequent stroke: a meta-analysis. BMJ 2005; 330: 342.
24. Im JA, Kim SH, Lee DC. Effects of Long term hormone therapy on
platelet activation in postmenopausal women. J Korean Acad Fam
Med 2004; 25: 754-9.
25. Park JK, Kim HJ, Chang SJ, Koh SB, Koh SY. Risk factors for hem-
orrhagic stroke in Wonju, Korea. Yonsei Med J 1998; 39: 229-35. 
1058 S.H. Choi, S.-M. Lee, Y. Kim, et al.
°